Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Immix Biopharma (IMMX): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
8 analysts
Options Flow (P/C)
—
Avg Consensus PT
$24
+134.6%
Highest Price Target
$30
+193.3%
Lowest Price Target
$19
+85.7%
Short Interest
16.3%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Needham | Gil Blum— | +193.3% | $21 → $30 | Maintained | Buy |
| Sep 15, 2026 | Mizuho | Graig Suvannavejh— | +154.2% | $15 → $26 | Maintained | Outperform |